Literature DB >> 18436846

Spatial profile of macular pigment and its relationship to foveal architecture.

John M Nolan1, James M Stringham, Stephen Beatty, D Max Snodderly.   

Abstract

PURPOSE: Macular pigment (MP) is composed of two dietary carotenoids, lutein and zeaxanthin, and a carotenoid generated by the retina, meso-zeaxanthin. There is large intersubject variability in peak optical density, spatial profile, and lateral extent of macular pigment, and it has been suggested that foveal architecture may play a role in this variability. This study is an initial investigation of the relationship between the spatial profile of macular pigment and foveal architecture.
METHODS: Sixty normal subjects were enrolled (one was eventually excluded). The spatial profile of macular pigment optical density (MPOD) was measured by customized heterochromatic flicker photometry (cHFP). High-resolution macular thickness maps were obtained by optical coherence tomography. Four parameters were analyzed: (1) minimum foveal thickness (MFT) at the intersection of six radial scans; (2) central foveal thickness (CFT) averaged over the central 1 mm of the fovea; (3) foveal width identified as the region lacking a nerve fiber layer; and (4) foveal width measured from crest to crest. Lifestyle and vision information were obtained by questionnaire.
RESULTS: The mean +/- SD MPOD at 0.25 degrees eccentricity was 0.49 +/- 0.23 and at 0.5 degrees eccentricity, 0.41 +/- 0.21. A first-order decreasing exponential function accounted for most of the variance of the MP profile averaged across subjects (r(2) = 0.99). MPOD measured at 0.25 degrees was unrelated to both measures of foveal thickness for the entire study group (r = 0.03, P = 0.81, and r = -0.08, P = 0.57, respectively). Similarly, MPOD measured at 0.5 degrees was unrelated to foveal thickness in the entire study group (r = 0.12, P = 0.36 and r = -0.05, P = 0.71, respectively). However, when analyzed separately in the nonwhite subjects, the relationship between MPOD at 0.25 degrees and MFT was positive and significant (r = 0.59, P = 0.01), but remained unrelated to CFT (r = 0.20, P = 0.41). Similarly, in the nonwhite subjects, the relationship between MPOD at 0.5 degrees and MFT was positive and significant (r = 0.68, P < 0.01), but again was unrelated to CFT (r = 0.23, P = 0.32). There was no significant relationship between MPOD and either measure of foveal thickness in the white subjects. In the entire study group, there was a positive and significant relationship between foveal width and MPOD averaged across the fovea (r = 0.41, P < 0.01) and between foveal width and MP integrated across the fovea (r = 0.41, P < 0.01).
CONCLUSIONS: Foveal MP was positively and significantly related to foveal width in the entire study group. This relationship may be determined by the greater length of the cone axons (Henle fibers) in wider foveas. MPOD was unrelated to foveal thickness in the white subjects. However, in the nonwhite subjects there was a positive association between MFT and MPOD at the 0.25 degrees and 0.5 degrees eccentricities, suggesting that other personal characteristics modulate the MPOD-retinal thickness relationship.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18436846     DOI: 10.1167/iovs.07-0933

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  43 in total

1.  Macular pigment optical density measurements: evaluation of a device using heterochromatic flicker photometry.

Authors:  R de Kinkelder; R L P van der Veen; F D Verbaak; D J Faber; T G van Leeuwen; T T J M Berendschot
Journal:  Eye (Lond)       Date:  2010-11-05       Impact factor: 3.775

2.  Measurement of macular pigment optical density among healthy Chinese people and patients with early-stage age-related macular degeneration.

Authors:  Xue-Tao Ren; Hong Gu; Xu Han; Jun-Yan Zhang; Xue Li; Xiu-Fen Yang; Jun Xu; Torkel Snellingen; Xi-Pu Liu; Ning-Li Wang; Ning-Pu Liu
Journal:  Int J Ophthalmol       Date:  2015-12-18       Impact factor: 1.779

3.  The macular pigment optical density spatial profile and increasing age.

Authors:  Raymond O Beirne
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-10-01       Impact factor: 3.117

4.  Heritability of the spatial distribution and peak density of macular pigment: a classical twin study.

Authors:  R E Hogg; E L Ong; M Chamberlain; M Dirani; P N Baird; R H Guymer; F Fitzke
Journal:  Eye (Lond)       Date:  2012-06-29       Impact factor: 3.775

Review 5.  Measuring macular pigment optical density in vivo: a review of techniques.

Authors:  Olivia Howells; Frank Eperjesi; Hannah Bartlett
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-01-08       Impact factor: 3.117

6.  The effects of ocular magnification on Spectralis spectral domain optical coherence tomography scan length.

Authors:  Irene Ctori; Stephen Gruppetta; Byki Huntjens
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-01-10       Impact factor: 3.117

7.  Macular pigment spatial distribution effects on glare disability.

Authors:  Christopher M Putnam; Carl J Bassi
Journal:  J Optom       Date:  2015-02-16

Review 8.  The putative role of lutein and zeaxanthin as protective agents against age-related macular degeneration: promise of molecular genetics for guiding mechanistic and translational research in the field.

Authors:  John Paul SanGiovanni; Martha Neuringer
Journal:  Am J Clin Nutr       Date:  2012-10-10       Impact factor: 7.045

9.  Effect of age and other factors on macular pigment optical density measured with resonance Raman spectroscopy.

Authors:  Akira Obana; Yuko Gohto; Masaki Tanito; Shigetoshi Okazaki; Werner Gellermann; Paul S Bernstein; Akihiro Ohira
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-03-11       Impact factor: 3.117

10.  Reliability of a commercially available heterochromatic flicker photometer, the MPS2, for measuring the macular pigment optical density of a Japanese population.

Authors:  Akira Obana; Yuko Gohto; Takatoshi Moriyama; Takahiko Seto; Hiroyuki Sasano; Shigetoshi Okazaki
Journal:  Jpn J Ophthalmol       Date:  2018-03-28       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.